MacroGenics (M55) Stock Statistics & Valuation Metrics
Total Valuation
MacroGenics has a market cap or net worth of EUR 136.43M. The enterprise value is EUR 318.75M.
- Market Cap
- EUR 136.43M
- Enterprise Value
- EUR 318.75M
Share Statistics
MacroGenics has 63,700,188 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 63,700,188
- Owned by Insiders
- 2.61%
- Owned by Institutions
- 29.59%
Financial Efficiency
MacroGenics’s return on equity (ROE) is -1.34 and return on invested capital (ROIC) is -32.98%.
- Return on Equity (ROE)
- -1.34
- Return on Assets (ROA)
- -0.29
- Return on Invested Capital (ROIC)
- -32.98%
- Return on Capital Employed (ROCE)
- -0.34
- Revenue Per Employee
- 510.24K
- Profits Per Employee
- -254.68K
- Employee Count
- 293
- Asset Turnover
- 0.58
- Inventory Turnover
- 5.46
Valuation Ratios
The current PE Ratio of MacroGenics is -10.91. MacroGenics’s PEG ratio is 0.09.
- PE Ratio
- -10.91
- PS Ratio
- 0.91
- PB Ratio
- 3.56
- Price to FCF
- -2.33
- Price to Operating Cash Flow
- -2.40
- PEG Ratio
- 0.09
Income Statement
In the last 12 months, MacroGenics had revenue of 149.50M and earned -74.62M in profits. Earnings per share was -1.18.
- Revenue
- 149.50M
- Gross Profit
- 106.32M
- Operating Income
- -72.84M
- Pretax Income
- -75.29M
- Net Income
- -74.62M
- EBITDA
- -59.61M
- Earnings Per Share (EPS)
- -1.18
Cash Flow
In the last 12 months, operating cash flow was -63.72M and capital expenditures -1.82M, giving a free cash flow of -65.54M billion.
- Operating Cash Flow
- -63.72M
- Free Cash Flow
- -65.54M
- Free Cash Flow per Share
- -1.03
Dividends & Yields
MacroGenics pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -42.87%
- Earnings Yield
- -9.56%
Stock Price Statistics
- Beta
- 0.45
- 52-Week Price Change
- 41.13%
- 50-Day Moving Average
- 3.29
- 200-Day Moving Average
- 2.98
- Relative Strength Index (RSI)
- 31.76
- Average Volume (3m)
- 2,684
Important Dates
MacroGenics upcoming earnings date is Nov 04, 2026, TBA (Not Confirmed).
- Last Earnings Date
- Aug 13, 2026
- Next Earnings Date
- Nov 04, 2026
- Ex-Dividend Date
- ―
Financial Position
MacroGenics as a current ratio of 5.10, with Debt / Equity ratio of 192.05%
- Current Ratio
- 5.10
- Quick Ratio
- 4.92
- Debt to Market Cap
- 0.74
- Net Debt to EBITDA
- -0.83
- Interest Coverage Ratio
- -8.56
Taxes
In the past 12 months, MacroGenics has paid -672.00K in taxes.
- Income Tax
- -672.00K
- Effective Tax Rate
- 0.01
Enterprise Valuation
MacroGenics EV to EBITDA ratio is -0.91, with an EV/FCF ratio of -1.13.
- EV to Sales
- 0.44
- EV to EBITDA
- -0.91
- EV to Free Cash Flow
- -1.13
- EV to Operating Cash Flow
- -1.16
Balance Sheet
MacroGenics has EUR 173.31M in cash and marketable securities with EUR 35.09M in debt, giving a net cash position of EUR 138.21M billion.
- Cash & Marketable Securities
- EUR 173.31M
- Total Debt
- EUR 35.09M
- Net Cash
- EUR 138.21M
- Net Cash Per Share
- EUR 2.17
- Tangible Book Value Per Share
- EUR 0.67
Margins
Gross margin is 50.44%, with operating margin of -24.30%, and net profit margin of -8.70%.
- Gross Margin
- 50.44%
- Operating Margin
- -24.30%
- Pretax Margin
- -62.34%
- Net Profit Margin
- -8.70%
- EBITDA Margin
- -48.75%
- EBIT Margin
- -52.26%
Analyst Forecast
The average price target for MacroGenics is EUR 6.29, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
- Price Target
- EUR 6.29
- Price Target Upside
- 199.64% Upside
- Analyst Consensus
- Moderate Buy
- Analyst Count
- 4
- Revenue Growth Forecast
- -4.85%
- EPS Growth Forecast
- 63.70%
Scores
- Smart Score
- 7
- AI Score
- ―